Back

Freshfields advised Mars, Inc. on the acquisition of the Cerba HealthCare Group’s stake in Cerba Vet and Antagene

Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) advised Mars, Inc. on the acquisition of a minority stake in the share capital and voting rights of Cerba Vet and of the entire share capital and voting rights of Antagene, specializing in veterinary medical diagnostics with a strong nexus in France and a presence in Switzerland.

The majority of the share capital and voting rights of Cerba Vet will remain owned by the existing veterinary shareholders in compliance with applicable regulatory rules.

The Freshfields team was led by partner Guillemette Burgala and counsel Radu Valeanu and Paul Bévierre, alongside senior associate Octavian David and associates Anne-Priscille Coulot, Naoufel Boudouda, Marine Valmont and Brieuc Trambouze. Advice on separation matters and commercial contracts was led by partner Giles Pratt, alongside senior associate Zofia Aszendorf and associate Tochukwu Egenti. Advice on regulatory aspects and foreign direct investment was provided by partner Pascal Cuche, alongside counsel Tanguy Bardet and associate Léa Hirschi. Advice on merger control aspects was provided by partner Alex Potter and counsel Sofia Bekkali. US corporate advice was provided by partner Paul Tiger and associate Victor Ma.

LEGAL DESIRE NEWSLETTER

Where the legal industry reads first.

Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.

No spam. Unsubscribe anytime.

From Legal Desire

Is your firm the one being cited, or the one being skipped?

We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.

Nitya Vashishtha
Nitya Vashishtha